Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_assertion type Assertion NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_head.
- NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_assertion description "[Variants at three of these loci have previously been linked with important clinical outcomes: SLC7A9 is a risk locus for chronic kidney disease, NAT2 for coronary artery disease and genotype-dependent response to drug toxicity, and SLC6A20 for iminoglycinuria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_provenance.
- NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_assertion evidence source_evidence_curated NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_provenance.
- NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_assertion SIO_000772 21572414 NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_provenance.
- NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_assertion wasDerivedFrom ctd_human-20150221 NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_provenance.
- NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_assertion wasGeneratedBy ECO_0000218 NP30261.RAkSDgMtOPI-6wC7RRns4NcSlQo6-a7oNW1ICdSKs6Zpw130_provenance.